DigiDiab Pilot Spain - Nursing Home and Domiciliary Nursing Care
Recruiting · NCT06605859 · Observational (researchers observe without assigning treatment) · Lead sponsor: Medical University of Graz
View the official record on ClinicalTrials.gov →Interventions studied
Diabetes TreatmentGlucoTab
What this trial is about
GlucoTab is a stand-alone software system to support healthcare professionals in the care of patients with diabetes mellitus or newly diagnosed hyperglycaemia who are treated with insulin and/or other glucose-lowering drugs or of patients only requiring glucose monitoring. It provides a therapy algorithm for subcutaneous basal insulin therapy of patients with type 2 diabetes, which will be used in this study.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Elderly people, willing to be treated with a basal insulin therapy according to the GlucoTab system
- Informed consent obtained after being advised of the nature of the study
- Male or female aged ≥ 18 years
- Type 2 diabetes (treated with insulin therapy)
- Residents of participating nursing homes/domiciliary nursing care in the region of Camp de Tarragona (Spain).
Exclusion criteria
- type 1 diabetes mellitus
- intravenous insulin therapy
- hyperglycaemic episodes (ketoacidosis, hyperosmolar state) if they require intravenous insulin therapy
- continuous subcutaneous insulin infusion
- gestational diabetes or pregnancy
- known or suspected allergy to insulin
- total parenteral nutrition
- any mental condition rendering the patient incapable of giving his/her consent
- any disease or condition which according to the investigator would interfere with the trial or the safety of the patient
Where it is running
1 location listed.
- IDIAP Jordi Gol - Tarragona, Spain